Cytosorbents Corporation
$0.34
-0.00 (-1.41%)
Price as of Aug 28, 2026 market close
Performance
- 1 Month
- -4.1%
- 3 Months
- -31.6%
- YTD
- -47.5%
- 1 Year
- -63.9%
Price return, based on split- and dividend-adjusted closing prices.
Risk
- Volatility 1-year annualized
- 77.3%
- Largest decline max drawdown, since Aug 2025
- -73.2%
- Risk-adjusted return Sharpe ratio, 1-year
- -0.93
Own CTSO?
See how CTSO contributes to your portfolio's return, allocation, and risk.
7-day free trial, then $9/month.